Hrt Financial LP Rani Therapeutics Holdings, Inc. Transaction History

Hrt Financial LP

  • $18.1 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
BUY
$2.98 - $3.8 $67,309 - $85,830
22,587 New
22,587 $70,000
Q2 2023

Aug 11, 2023
BUY
$3.92 - $5.58 $91,116 - $129,701
23,244 Added 128.43%
41,342 $170,000
Q1 2023

May 12, 2023
BUY
$5.07 - $6.89 $91,756 - $124,695
18,098 New
18,098 $93,000

Others Institutions Holding RANI

# of Institutions
35
Shares Held
5.77M
Call Options Held
2.5K
Put Options Held
2.2K
View Full List

About Rani Therapeutics Holdings, Inc.

RANI Quotes by TradingView
  • Ticker RANI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,492,000
  • Market Cap $35.8M
  • Description
  • Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed P...
More about RANI
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email